Antonio Belli is a Professor of Trauma Neurosurgery and Director of the Surgical Reconstruction and Microbiology Research Centre based at the Queen Elizabeth Hospital Birmingham. He heads the neurotrauma research theme, which carries out translational research on traumatic brain injury and spinal cord injury. He is also a practicing neurosurgeon at Queen Elizabeth Hospital, where he leads the neurotrauma service, which comprises a formidable team of doctors, nurses and therapists. He graduated from Tor Vergata University in Rome with a degree in Medicine and Surgery. He completed his MD in neurobiochemistry of brain ischaemia and reperfusion at Tor Vergata University. He trained as a neurosurgeon at King’s College Hospital, Atkinson Morley’s Hospital, the National Hospital for Neurology and Neurosurgery, Great Ormond Street Hospital, the Royal Free Hospital and Charing Cross Hospital. He carried out a research fellowship in neuromonitoring at the Institute of Neurology in London (2001–2003). His research interest is in neurobiochemistry and neuromonitoring of acute brain injury. A particular focus is brain metabolism following mild and severe traumatic brain injury and how this relates to the long-term outcome and the risk of early neurogenerative conditions. Working with cerebral microdialysis, another area of interest is early markers of tissue damage for the prevention of secondary injury after trauma and subarachnoid haemorrhage, patient stratification and drug discovery.
Antonio Belli is a Professor of Trauma Neurosurgery and Director of the Surgical Reconstruction and Microbiology Research Centre based at the Queen Elizabeth Hospital Birmingham. He heads the neurotrauma research theme, which carries out translational research on traumatic brain injury and spinal cord injury. He is also a practicing neurosurgeon at Queen Elizabeth Hospital, where he leads the neurotrauma service, which comprises a formidable team of doctors, nurses and therapists. He graduated from Tor Vergata University in Rome with a degree in Medicine and Surgery. He completed his MD in neurobiochemistry of brain ischaemia and reperfusion at Tor Vergata University. He trained as a neurosurgeon at King’s College Hospital, Atkinson Morley’s Hospital, the National Hospital for Neurology and Neurosurgery, Great Ormond Street Hospital, the Royal Free Hospital and Charing Cross Hospital. He carried out a research fellowship in neuromonitoring at the Institute of Neurology in London (2001–2003). His research interest is in neurobiochemistry and neuromonitoring of acute brain injury. A particular focus is brain metabolism following mild and severe traumatic brain injury and how this relates to the long-term outcome and the risk of early neurogenerative conditions. Working with cerebral microdialysis, another area of interest is early markers of tissue damage for the prevention of secondary injury after trauma and subarachnoid haemorrhage, patient stratification and drug discovery.